HighGravityDataFMC Corporation — Apr 29, 2026 release
Fiscal 2026 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000037785-26-000083
Showing in the filing
Revenue Excl. India
“$1.99 billion to $2.14 billion”
Period
H2 FY2026
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 35
EPS (Adjusted earnings per diluted share) for FY2026
“$1.63 to $1.89”
Debt reduction for FY2026
“approximately $1 billion”
Price for FY2026
“lower by mid-single digits”
Volume (excluding India) for FY2026
“up modestly”
India headwind for FY2026
“2 percent headwind”
Sales of new active ingredients for FY2026
“between $300 million and $400 million”
Free cash flow for FY2026
“negative $65 million to $65 million dollars”
Revenue for Q2 FY2026
“$850 million to $900 million”
Price for Q2 FY2026
“decline mid-single digits”
Second-half sales for H2 FY2026
“increase of 1 percent”
Second-half Adjusted EBITDA for H2 FY2026
“decrease 6 percent”
Second-half Adjusted EPS for H2 FY2026
“decline 15 percent”
Revenue (excl. India) for FY2026
“$3.60 billion to $3.80 billion”
Revenue Excl. India for Q2 FY2026
“$850 million to $900 million”
Revenue Excl. India for Q2 FY2025
“$850 million to $900 million”
Revenue Excl. India for H1 FY2026
“$1.61 billion to $1.66 billion”
Revenue Excl. India for H2 FY2026
“$1.99 billion to $2.14 billion”
Adjusted EBITDA Growth at midpoint vs. 2025 for FY2026
“(17)%”
Revenue Excl. India Growth at midpoint vs. 2… for FY2026
“(11)%”
Adjusted EBITDA for FY2026
“$670 million to $730 million”
Adjusted EBITDA for Q2 FY2026
“$130 million to $150 million”
Adjusted EBITDA for Q2 FY2025
“$130 million to $150 million”
Adjusted EBITDA for H1 FY2026
“$202 million to $222 million”
Adjusted EBITDA for H2 FY2026
“$468 million to $508 million”
Revenue Excl. India Growth at midpoint vs. 2… for Q2 FY2026
“(17)%”
Growth at midpoint vs. 2025* for Q2 FY2025
“(17)%”
Adjusted EBITDA Growth at midpoint vs. 2025 for Q2 FY2026
“(32)%”
Adjusted EPS for Q2 FY2026
“$0.16 to $0.26”
Adjusted EPS^ for Q2 FY2025
“$0.16 to $0.26”
Adjusted EPS^ for H1 FY2026
“$(0.07) to $0.03”
Adjusted EPS^ for H2 FY2026
“$1.70 to $1.86”
Adjusted EPS Growth at midpoint vs. 2025 for Q2 FY2026
“(70)%”
Adjusted EPS Growth at midpoint vs. 2025 for FY2026
“(102)%”
Growth at midpoint vs. 2025* for H1 FY2026
“(102)%”
Growth at midpoint vs. 2025* for H2 FY2026
“(15)%”
Exhibit 99.1 · the passage around this item
… earlier in the release
Page 5 / FMC Corporation reports first quarter 2026 results above guidance with Adjusted EBITDA above high end of range, reaffirms full-year outlook Full-Year 2026 Outlook 1 Q2 2025 Outlook 1 First-Half Outlook 1 Second-Half Outlook 1 Revenue Excl. India $3.60 billion to $3.80 billion $850 million to $900 million $1.61 billion to $1.66 billion $1.99 billion to $2.14 billion Growth at midpoint vs. 2025* (5)% (17)% (11)% 1% Adjusted EBITDA $670 million to $730 million $130 million to $150 million $202 million to $222 million $468 million to $508 million Growth at midpoint vs. 2025* (17)% (32)% (35)% (6)% Adjusted EPS^ $1.63 to $1.89 $0.16 to $0.26 $(0.07) to $0.03 $1.70 to $1.86 Growth at midpoint vs. 2025* (41)% (70)% (102)% (15)% ^ EPS estimates assume 125.9 million diluted shares for full year, Q2 and H2; 125.3 million diluted shares for H1. *Percentages are calculated using whole numbers. Minor differences may exist due to rounding. India excluded from 2026 guidance and H2 2025 actuals. Variances are calculated versus 2025 results, which include India in the first half of the year. Supplemental Information The company will post supplemental information on the web at https://investors.fmc.com, including its webcast slides for tomorrow’s earnings call, definitions of non-GAAP terms and reconciliations of non-GAAP figures to the nearest available GAAP term. Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. FMC and the
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.